No Data
No Data
Express News | DAY3 Reports FY24Q4 Revenue of RM20.35 Million
DAY3: Quarterly rpt on consolidated results for the financial period ended 31/12/2024
Day One Biopharmaceuticals Announces $57.2M Preliminary 2024 OJEMDA Revenue, Cleared Phase 1a/b DAY301 Dose Cohort, $531.7M In Cash, To Present At J.P. Morgan Healthcare Conference Today At 6:45 P.m. Eastern Time
Express News | DAY3 Reports FY24Q3 Attributable Profit of RM2.93 Million, Up 205.6% YoY
DAY3: Quarterly rpt on consolidated results for the financial period ended 30/09/2024
Daythree Digital Berhad's (KLSE:DAY3) Problems Go Beyond Weak Profit
Lawrence81 : Great in-depth review.